Unique as a Fingerprint
Update on how some companies are embracing personalized medicine in oncology testing
Read More
Search Results for: lung cancer
Abbott Receives FDA Clearance for ALK FISH Test
The new Abbott Vysis ALK Break Apart FISH Probe test is designed to identify ALK-positive NSCLC patients for Pfizer’s approved NSCLC therapy, XALKORI (crizotinib), an oral ALK inhibitor.
Read More
Biocare’s Legacy: Diagnostic Power Through Multiplex IHC
Biocare Medical’s innovations are grounded in patient care, says David Tacha, HTL (ASCP), PhD, vice president of R&D, chief scientific officer, and one of the company’s founders. When you walk into the lab of David Tacha, HTL (ASCP), P
Read MoreLeica Biosystems, China Medical Technologies Inc Enter Research and Development Collaboration
China Medical Technologies Inc (CMED) and Leica Biosystems, a have established a sales, research, and development collaboration to codevelop automated FISH kits.
Read More
Quest Diagnostics
An Interview with Jon R. Cohen, MD, senior VP and chief medical officer, Quest Diagnostics
Read More